Growth Metrics

Inspire Medical Systems (INSP) Gains from Investment Securities (2017 - 2025)

Inspire Medical Systems (INSP) has disclosed Gains from Investment Securities for 9 consecutive years, with -$8.0 million as the latest value for Q4 2025.

  • Quarterly Gains from Investment Securities fell 627.82% to -$8.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$3.5 million through Dec 2025, down 354.55% year-over-year, with the annual reading at $2.1 million for FY2025, 39.16% up from the prior year.
  • Gains from Investment Securities hit -$8.0 million in Q4 2025 for Inspire Medical Systems, down from $4.0 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $10.6 million in Q3 2022 to a low of -$8.0 million in Q4 2025.
  • Historically, Gains from Investment Securities has averaged $475411.8 across 5 years, with a median of $8000.0 in 2021.
  • Biggest five-year swings in Gains from Investment Securities: tumbled 1622.22% in 2021 and later skyrocketed 9119.66% in 2022.
  • Year by year, Gains from Investment Securities stood at -$50000.0 in 2021, then soared by 21206.0% to $10.6 million in 2022, then crashed by 102.37% to -$250000.0 in 2023, then skyrocketed by 706.8% to $1.5 million in 2024, then plummeted by 627.82% to -$8.0 million in 2025.
  • Business Quant data shows Gains from Investment Securities for INSP at -$8.0 million in Q4 2025, $4.0 million in Q2 2025, and $512000.0 in Q1 2025.